top of page

Lilia Coburn-Martinez, MBA

Administrative and Clinical Engagement Coordinator

Lilia Coburn brings 20 years of development of consumer engagement and behavior change products experience. She is Chief Product Officer at Bullpen, pioneering AI-enabled applications for financial services automation, and also serves as Fractional CPO at AllaiHealth and Advisor and Bullpen CPO at Emerge9, advancing AI-driven innovations in healthcare and alternative asset management. As Founding Partner of Heart, she helps early-stage startups refine product narratives and achieve product-market fit. Previously, Lilia was Director of Product at 23andMe and President of MedHelp (a Merck subsidiary), where she led development of a behaviorally informed health management platform that powered Vascular Cures’ Project Voice. She has led product and engineering teams in the development and commercialization of consumer products in Silicon Valley, ranging from early-stage startups to top Fortune 500 companies. Her personal mission is to combine her high-tech background, her expertise in user experience and consumer engagement, and her passion for health and behavioral design, to spur innovative and effective preventive healthcare solutions. She holds a B.S. in Electrical Engineering from the University of Miami, and an MBA from the UC Berkeley Haas School of Business.

Lilia Coburn-Martinez, MBA

Subscribe to Our Newsletter

Get the latest updates on research, events, and ways to get involved.

Subscribe

Your gift helps advance patient-centered research, education, and community health initiatives that support those affected by vascular disease.

La Fundación para el Avance de las Curas Vasculares es una organización sin fines de lucro exenta de impuestos (número de identificación fiscal: 94-2825216), conforme a la Sección 501(c)(3) del Código de Impuestos Internos. Las donaciones son deducibles de impuestos.
Copyright © 2024 Fundación para el Avance de las Curas Vasculares. Todos los derechos reservados.

bottom of page